7917
ZACROS Corporation
ＺＡＣＲＯＳ株式会社ZACROS Corporation manufactures and sells products for wellness environmental solutions, electronic materials, and industrial infrastructure in Japan and internationally. It operates through four segments: Wellness Business, Environmental Solutions Business, Electronic Materials Business, and Industrial Infrastructure Business. The company offers wellness products, including MediTect IV Bag, a non-adsorbing, low-leaching packaging for ready-to-use (RTU) drugs; BioPhas, a customized service that is used in single-use products for biopharmaceuticals manufacturing; and Total Thrombus formation Analysis System, a flow chamber system. It also provides environmental solutions, such as flexible refill pouches; liquid containers; and high performance / high clean packaging. In addition, the company offers protective films; coating commissioned processing services; and free standing electrode, as well as adhesive films, release liners, tab seal film, and industrial laminate film. Further, it engages in industrial infrastructure activities. The company was formerly known as Fujimori Kogyo Co., Ltd. and changed its name to ZACROS Corporation in October 2024. ZACROS Corporation was founded in 1914 and is headquartered in Tokyo, Japan.
Price
¥1,267
Market Cap
¥23.5B
Ent. Value
¥19.1B
Net Cash
¥4.4B
Shares Out.
18.5M
P / E
11.9×
EV / EBIT
1.7×
P / Book
0.96×
P / NCAV
0.84×
Div. Yield
5.68%
Financials
| Metric |
FY 2025
TDnet |
FY 2024
EDINET ↗ |
FY 2023
EDINET ↗ |
FY 2022
EDINET ↗ |
FY 2021
EDINET ↗ |
|---|---|---|---|---|---|
| Net Sales | ¥158.5B | ¥150.7B | ¥136.2B | ¥129.4B | ¥127.8B |
| Cost of Sales | ¥121.7B | ¥116.0B | ¥106.4B | ¥103.7B | ¥99.1B |
| Gross Profit | ¥36.8B | ¥34.7B | ¥29.7B | ¥25.7B | ¥28.7B |
| SG&A | ¥25.8B | ¥24.6B | ¥21.4B | ¥19.8B | ¥18.3B |
| Operating Income | ¥11.1B | ¥10.1B | ¥8.3B | ¥5.9B | ¥10.3B |
| Non-Operating Income | ¥1.6B | ¥941M | ¥678M | ¥1.0B | ¥826M |
| Dividend Income | — | ¥65M | ¥75M | ¥230M | ¥118M |
| Interest Income | — | ¥299M | ¥170M | ¥70M | ¥63M |
| Non-Operating Expenses | — | ¥692M | ¥112M | ¥62M | ¥65M |
| Interest Expense | — | ¥135M | ¥73M | ¥46M | ¥18M |
| Ordinary Income | ¥12.3B | ¥10.4B | ¥8.9B | ¥6.8B | ¥11.1B |
| Pre-tax Income | ¥11.4B | ¥9.6B | ¥7.2B | ¥7.6B | ¥11.1B |
| Income Taxes | ¥2.7B | ¥2.2B | ¥2.1B | ¥1.9B | ¥2.7B |
| Current Tax | — | ¥2.3B | ¥2.7B | ¥1.9B | ¥2.6B |
| Deferred Tax | — | ¥-165M | ¥-548M | ¥12M | ¥75M |
| Net Income (owners) | ¥7.7B | ¥6.5B | ¥4.5B | ¥4.9B | ¥7.7B |
| Minority Interest | — | ¥916M | ¥572M | ¥877M | ¥729M |
| Comprehensive Income | — | ¥9.6B | ¥6.3B | ¥6.5B | ¥9.0B |
| EBITDA | ¥18.0B | ¥16.2B | ¥14.3B | ¥11.2B | ¥15.8B |
| Goodwill Amort. (J-GAAP) | — | ¥67M | ¥65M | ¥62M | ¥54M |
| EPS | ¥106.14 | ¥351.26 | ¥241.43 | ¥255.68 | ¥403.60 |
| Shares Outstanding | — | 18.5M | 18.6M | 18.8M | 19.0M |
| Shares Issued (total) | — | 19.3M | 19.3M | 19.3M | 19.3M |
| Treasury Shares | — | 0.8M | 0.7M | 0.5M | 0.2M |